NCT03197324View on ClinicalTrials.gov

Bexagliflozin Drug/Drug Interaction Study With Digoxin

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 24, 2017

Primary Completion Date

September 17, 2017

Study Completion Date

September 17, 2017

Conditions
Type2 Diabetes Mellitus
Interventions
DRUG

Bexagliflozin

Bexagliflozin tablets, 20 mg

DRUG

Digoxin

2 0.25 mg Digoxin tablets (total dose 0.5 mg digoxin)

Trial Locations (1)

32117

Covance CRU, Daytona Beach

Sponsors

Lead Sponsor

Theracos
All Listed Sponsors
lead

Theracos

INDUSTRY

NCT03197324 - Bexagliflozin Drug/Drug Interaction Study With Digoxin | Biotech Hunter | Biotech Hunter